Form 4 Tracker
Martin Wilson

General Counsel · 5 filings · Latest: May 19, 2026

ROCKET PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RCKT
Wilson MartinAug 13, 2026
Proposed Sale
$3.383,493$11.8K
RCKT
Martin WilsonGeneral CounselMay 19, 2026
Sale
$3.01662$2.0K677,977
RCKT
Wilson MartinMay 19, 2026
Proposed Sale
$3.01662$2.0K
RCKT
Martin WilsonGeneral CounselMay 13, 2026
Sale
$3.613,361$12.1K678,639
RCKT
Wilson MartinMay 13, 2026
Proposed Sale
$3.613,361$12.1K
RCKT
Martin WilsonGeneral CounselFeb 18, 2026
Sale
$3.341,376$4.6K682,000
RCKT
Martin WilsonGeneral CounselFeb 13, 2026
Sale
$3.3112,253$40.6K683,376
RCKT
Wilson MartinFeb 18, 2026
Proposed Sale
$3.341,376$4.6K
RCKT
Wilson MartinFeb 13, 2026
Proposed Sale
$3.3112,253$40.6K
RCKT
Wilson MartinNov 18, 2025
Proposed Sale
$2.981,646$4.9K
RCKT
Wilson MartinAug 19, 2025
Proposed Sale
$3.00588$1.8K
RCKT
Wilson MartinAug 18, 2025
Proposed Sale
$3.071,004$3.1K
RCKT
Wilson MartinAug 14, 2025
Proposed Sale
$3.0212,109$36.6K
RCKT
Wilson MartinMay 20, 2025
Proposed Sale
$6.45587$3.8K
RCKT
Wilson MartinMay 16, 2025
Proposed Sale
$6.53946$6.2K
RCKT
Wilson MartinFeb 21, 2025
Proposed Sale
$10.583,222$34.1K
RCKT
Wilson MartinNov 21, 2024
Proposed Sale
$13.051,175$15.3K